---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-002525"
form_type: "8-K"
ticker: "GCTK"
cik: "0001506983"
company_name: "Glucotrack, Inc."
filed_at: "2025-04-03T23:59:59+00:00"
generated_at: "2026-05-23T22:31:38.980225+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "medium"
source: SEC EDGAR
---

# Glucotrack partners with OneTwo Analytics for AI-driven clinical data analysis of implantable CBGM

## Summary
- Glucotrack (GCTK) enters collaboration with OneTwo Analytics AB to apply AI/ML analytics on its CBGM clinical study data.
- CBGM is a long-term implantable device that measures glucose directly from blood, no external component, 3-year sensor life.
- OneTwo Analytics specializes in diabetes data analytics; collaboration aims to quantify long-term benefits of CBGM.
- No financial terms disclosed; agreement focuses on data analysis for clinical evaluation.

## SEC filing metadata
- accession: 0001641172-25-002525
- form_type: 8-K
- ticker: GCTK
- cik: 0001506983
- company_name: Glucotrack, Inc.
- filed_at: 2025-04-03T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506983/000164117225002525/0001641172-25-002525-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506983/000164117225002525/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-002525
- JSON: https://secwatch.observer/filing/0001641172-25-002525.json
- Plain text: https://secwatch.observer/filing/0001641172-25-002525.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.